HealthTech & AI

Discover how artificial intelligence and healthtech are transforming healthcare and drug development.

Nicole Dale

Midjourney Medical: The AI Image Pioneer’s Unexpected Healthcare Play

Digital human body visualisation representing Midjourney Medical, showcasing AI-powered whole-body imaging, preventative healthcare technology, advanced medical scanning, and personalised health intelligence.

Midjourney Medical is bringing AI, full-body imaging, and preventative care together. Could this unexpected move reshape healthcare delivery?

Nicole Dale

The AI Bioweapons Risk: We Cannot Afford to Look Away

Abstract visualisation of AI bioweapons risk showing a connected hexagonal network and glowing AI hub, symbolising biosecurity challenges, gene synthesis screening vulnerabilities, biotechnology innovation, and governance in the pharmaceutical industry.

The risk of AI being used to create a bioweapon is a serious concern for pharma biosecurity after researchers found AI-designed toxins can evade DNA screening. Here’s what you need to know about the AI and bioweapons risk.

Nicole Dale

Where Healthcare AI Investment Is Going — And Where It Isn't

Healthcare AI investment visualisation showing an advanced artificial intelligence network connected to pharmaceutical research, molecular data, and digital health systems. The image represents AI investment trends in healthcare, pharmaceutical innovation, biotech intelligence, machine learning in drug discovery, and the future of healthcare technology.

The data is out: Two-thirds of AI healthcare startup investment went to just three domains. Insight into clinical leadership, gender inclusivity, and geographical access reveals a sector building for investability… not clinical need.

Nicole Dale

First Quarter 2026 State of Digital Health Funding

A blue graphic featuring an upward-trending bar chart and line graph, representing digital health funding Q1 2026, set against a background of close-up medicine pills.

Digital health funding hit $7.4B in Q1 2026, the highest since Q2 2022. The CB Insights State of Digital Health report reveals where capital is concentrating and why it matters for pharma leaders.

Nicole Dale

What Pharma R&D Tech Investment Committees Actually Fund

What do pharma R&D tech investment committees really fund? Learn how workflow fit, enterprise pull, and strategic relevance drive adoption.

Nicole Dale

Strategic Pharma Intelligence Drives Better Decisions in Life Sciences

Strategic pharma intelligence concept featuring Pharmatica branding, molecular structures, global business leaders in discussion, and pharmaceutical innovation imagery, representing data-driven decision-making, industry analysis, and executive strategy in the life sciences sector.

Find out why strategic pharma intelligence is needed to connect insights and to guide confident decision-making across the drug development lifecycle.

Content type